alexa Problem of Vascular Access in Hemodialysis as First Choice Treatment in Senegal | OMICS International
ISSN: 2472-1220
Journal of Kidney
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Problem of Vascular Access in Hemodialysis as First Choice Treatment in Senegal

Kane Y1*, Diouf C1, Barboza D1, Seck SM3, Cisse MM2, Lemrabott AT2, Faye M2, Ka EF2, Niang A2 and Diouf B2

1Nephrology Department, Internal Medicine and General Surgery of Assane Seck University/Ziguinchor, Senegal

2Nephrology Department of Teaching Hospital Aristide Le Dantec /Dakar, Senegal

3Nephrology Department of Gaston Berger University/Saint Louis, Senegal

*Corresponding Author:
Yaya Kane
Nephrology department
Internal Medicine and General Surgery of Assane Seck University/Ziguinchor, Senegal
Tel:
0022177 500 21 65
E-mail: [email protected]

Received Date: January 01, 2016; Accepted Date: January 15, 2016; Published Date: January 30, 2016

Citation: Kane Y, Diouf C, Barboza D, Seck SM, Cisse MM, et al. (2016) Problem of Vascular Access in Hemodialysis as First Choice Treatment in Senegal. J Kidney 2:113. doi:10.4172/2472-1220.1000113

Copyright: © 2016 Kane Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Kidney

 

Commentary

Vascular access is of paramount importance for successful hemodialysis sessions. Any malfunction of the vascular access has a direct impact on morbidity and mortality of the patient under dialysis. Native arteriovenous fistula remains the standard and first line vascular access. This offers the best performance, greater longevity and lower morbidity [1].

Brecia and Cimino [2] were the first to describe a vascular procedure in creating an arterio-venous fistula (AVF) by performing a surgical anastomosis of the radial artery and the cephalic vein. However, there is a wide disparity in terms of geographic regions and centers in the methods of use of vascular access [3].

So in Senegal, in 89.20% of our chronic hemodialysis patients the first hemodialysis was performed using a central venous line, and only 10.80% had started their hemodialysis session with arteriovenous fistula. In a previous study performed in another center in 2010 [4], there was a finding that transitory catheter was performed in 86.6% of the cases.

The use of temporary central catheters as first choice treatment for our dialysis patients were well beyond the 10-20% recommended in the good practice guidelines [5]. However this can be explained by the fact that dialysis session was carried out as an emergency measure in the majority of our patients. Only patients whose entry into dialysis was planned received an AVF as first vascular access. In North America and Europe where over 80% of patients consult a nephrologist at least one month before entry into dialysis, temporary access only accounts for 2-3% of the patients [6].

The difference with our results could be explained by the fact that patients are examined by nephrologists late, and also that some patients attended by nephrologists are referred to vascular surgeons late.

Therefore low rate in our population is also explained by the fact that AVF administration is centralized in a single vascular surgery service for the whole country with a long scheduling period and especially that patients are not monitored in nephrology before dialysis.

For better quality of care in hemodialysis by good vascular access based on AVF, the recommendations are as follows:

1. Refer patients to vascular surgery in time for creation of the AVF as soon as creatinine clearance is below 30 ml/minute.

2. Set up a venous capital preservation strategy in all patients with kidney impairment avoiding venipuncture in the arm and forearm.

3. Start performing AVF in all regional hospitals of the country.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 7961
  • [From(publication date):
    March-2016 - Dec 11, 2017]
  • Breakdown by view type
  • HTML page views : 7892
  • PDF downloads : 69

Review summary

  1. Gregory Fuller
    Posted on Oct 21 2016 at 6:52 pm
    The author gave his expert comments on the various factors associated with vascular access in hemodialysis. The opinions are interesting and clinical significant. The recommendations listed in the article may be used as clinical standards for hemodialytic treatment.
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version